Androgen levels in older men who have or who are at risk of acquiring HIV infection

Clinical Infectious Diseases

Volumn 41, Issue 12, 2005, Pages 1794-1803

  Klein, Robert S ^a,c   Lo, Yungtai ^a   Santoro, Nanette ^a   Dobs, Adrian S ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; TESTOSTERONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANDROGEN BLOOD LEVEL; ANDROGEN DEFICIENCY; ARTICLE; BODY MASS; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGONADOTROPIC HYPOGONADISM; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; SYMPTOMATOLOGY;

AGED; AGED, 80 AND OVER; ANDROGENS; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HUMANS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TESTOSTERONE;

EID: 28744439315     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/498311     Document Type: Article

References (40)

1. Dobs AS, Dempsey MA, Ladenson PW, Polk BF. Endocrine disorders in men infected with human immunodeficiency virus. Am J Med 1988; 84:611-6.
2. Dobs AS, Few WL, Blackman MR, Harman SM, Hoover DR, Graham NM. Serum hormones in men with human immunodeficiency virus-associated wasting. J Clin Endocrinol Metab 1996; 81:4108-12.
3. Rietschel P, Corcoran C, Stanley T, Basgoz N, Klibanski A, Grinspoon S. Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. Clin Infect Dis 2000; 31:1240-4.
4. Araujo AB, O'Donnell AB, Brambilla DJ, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts male aging study. J Clin Endocrinol Metab 2004; 89:5920-6.
5. McLachlan RI, Allan CA. Defining the prevalence and incidence of androgen deficiency in aging men: where are the goal posts. J Clin Endocrinol Metab 2004; 89:5916-9.
6. Palella FJJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338:853-60.
7. Detels R, Munoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA 1998; 280:1497-503.
8. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133:21-30.
9. Strasfeld L, Lo Y, Netski D, Thomas DL, Klein RS. Prevalence, activity, and genotype of hepatitis C virus infection in a cohort of New York City drug users. J Acquir Immune Defic Syndr 2003; 33:356-64.
10. Wilshire GB, Loughlin JS, Brown JR, Adel TE, Santoro N. Diminished function of the somatotropic axis in older reproductive-aged women. J Clin Endocrinol Metab 1995; 80:608-13.
11. Santoro N, Adel T, Skurnick JH. Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women. Fertil Steril 1999; 71:658-62.
12. The Endocrine Society. Summary from the 2nd Annual Andropause Consensus Meeting (Chevy Chase, MD). Chevy Chase, MD: The Endocrine Society Continuing Medical Education Services, 2001.
13. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001; 86:724-31.
14. Villette JM, Bourin P, Doinel C, et al. Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus. J Clin Endocrinol Metab 1990; 70:572-7.
15. Grinspoon S, Corcoran C, Lee K, et al. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J Clin Endocrinol Metab 1996; 81:4051-8.
16. Cicero TJ. Effects of exogenous and endogenous opiates on the hypothalamic-pituitary-gonadal axis in the male. Fed Proc 1980; 39:2551-4.
17. Cicero TJ, O'Connor L, Nock B, et al. Age-related differences in the sensitivity to opiate-induced perturbations in reproductive endocrinology in the developing and adult male rat. J Pharmacol Exp Ther 1989; 248:256-61.
18. Yilmaz B, Konar V, Kutlu S, et al. Influence of chronic morphine exposure on serum LH, FSH, testosterone levels, and body and testicular weights in the developing male rat. Arch Androl 1999; 43:189-96.
19. Bannister P, Handley T, Chapman C, Losowsky MS. Hypogonadism in chronic liver disease: impaired release of luteinising hormone. Brit Med J (Clin Res Ed) 1986; 293:1191-3.
20. Gursoy S, Baskol M, Ozbakir O, Guven K, Kelestimur F, Yucesoy M. Hypothalamo-pituitary gonadal axis in men with chronic hepatitis. Hepatogastroenterology 2004; 51:787-90.
21. Ferri C, Bertozzi MA, Zignego AL. Erectile dysfunction and hepatitis C virus infection. JAMA 2002; 288:698-9.
22. Rzeszowska G, Jagiello-Wojtowicz E, Krawczuk G, et al. Level of prolactin, gonadotrophin, testosterone, and alpha fetoprotein in serum of blood donors with antibodies to hepatitis C virus (anti-HCV). Przegl Epidemiol 1993; 47:21-4.
23. Hendrick V, Gitlin M, Altshuler L, Korenman S. Antidepressant medications, mood and male fertility. Psychoneuroendocrinology 2000; 25:37-51.
24. Misra M, Papakostas GI, Klibanski A. Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. J Clin Psychiatry 2004; 65:1607-18.
25. Gapstur SM, Gann PH, Kopp P, Colangelo L, Longcope C, Liu K. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev 2002; 11:1041-7.
26. Glass AR, Swerdloff RS, Bray GA, Dahms WT, Atkinson RL. Low serum testosterone and sex-hormone-binding-globulin in massively obese men. J Clin Endocrinol Metab 1977; 45:1211-9.
27. Freedman DS, O'Brien TR, Flanders WD, DeStefano F, Barboriak JJ. Relation of serum testosterone levels to high density lipoprotein cholesterol and other characteristics in men. Arterioscler Thromb 1991; 11:307-15.
28. Ellis L, Nyborg H. Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health. Steroids 1992; 57:72-5.
29. Winters SJ, Brufsky A, Weissfeld J, Trump DL, Dyky MA, Hadeed V. Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism 2001; 50:1242-7.
30. Ettinger B, Sidney S, Cummings SR, et al. Racial differences in bone density between young adult black and white subjects persist after adjustment for anthropometric, lifestyle, and biochemical differences. J Clin Endocrinol Metab 1997; 82:429-34.
31. Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency. Metabolism 2000; 49:1239-42.
32. Smith KW, Feldman HA, McKinlay JB. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadisms) in ageing men. Clin Endocrinol (Oxf) 2000; 53:703-11.
33. Swerdloff RS, Blackman MR, Cunningham GR, Dobs AS, Iranmanesh A, Matsumoto AM. Summary of the consensus session from the 1st Annual Andropause Consensus 2000 Meeting. Bethesda, MD: Endocrine Society, 2000:1-6.
34. Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 2002; 57:M76-99.
35. Shores MM, Sloan KL, Matsumoto AM, Moceri VM, Felker B, Kivlahan DR. Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry 2004; 61:162-7.
36. Grinspoon S, Corcoran C, Stanley T, Baaj A, Basgoz N, Klibanski A. Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men. J Clin Endocrinol Metab 2000; 85:60-5.
37. Brown R, Balousek S, Mundt M, Fleming M. Methadone maintenance and male sexual dysfunction. J Addict Dis 2005; 24:91-106.
38. Veldhuis JD, King JC, Urban RJ, et al. Operating characteristics of the male hypothalamo-pituitary-gonadal axis: pulsatile release of testosterone and follicle-stimulating hormone and their temporal coupling with leutinizing hormone. J Clin Endocrinol Metab 1987; 65:929-41.
39. Institute of Medicine. Testosterone and aging: clinical research directions. Washington, DC: The National Academies Press, 2004.
40. Christ-Crain M, Meier C, Huber P, Zimmerli L, Trummler M, Muller B. Comparison of different methods for the measurement of serum testosterone in the aging male. Swiss Med Wkly 2004; 134:193-7.